Inhalation and Respiratory Drug Delivery
Inhalation and Respiratory Drug Delivery is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 34k research works in it since 1950. 18.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on advancements in pulmonary drug delivery techniques, including the use of inhaler devices, nanoparticles, aerosol therapy, and dry powder inhalers. It explores topics such as respiratory tract deposition, lung diseases, nanomedicine, and the delivery of inhaled insulin.
- Pulmonary Drug Delivery
- Inhaler Devices
- Nanoparticles
- Aerosol Therapy
- Particle Engineering
- Respiratory Tract Deposition
- Dry Powder Inhalers
- Lung Diseases
- Nanomedicine
- Inhaled Insulin
- Research works
- 34k fractional, since 1950
- In the world top 10%
- 6.2k per year above
- Top-10% rate
- 18.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +28% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Inhalation and Respiratory Drug Delivery research?
By volume, the United States and China publish the most (1.1k and 650 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.1k works
- 2 China 650 works
- 3 India 379 works
- 4 United Kingdom 366 works
- 5 Germany 226 works
- 6 Italy 192 works
- 7 Canada 167 works
- 8 Japan 160 works
- 9 France 150 works
- 10 Spain 134 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Inhalation and Respiratory Drug Delivery research?
By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most Inhalation and Respiratory Drug Delivery research, followed by Imperial College London and Trudell Medical International (Canada).
By volume, 2022–2025
- 1 University of North Carolina at Chapel HillUnited States 36 works
- 2 Imperial College LondonUnited Kingdom 22 works
- 3 Trudell Medical International (Canada)Canada 17 works
- 4 University of MichiganUnited States 14 works
- 5 The University of SydneyAustralia 14 works
- 6 University of ParmaItaly 14 works
- 7 University of GroningenNetherlands 13 works
- 8 InsermFrance 13 works
- 9 University of IowaUnited States 13 works
- 10 Sichuan UniversityChina 12 works
Who are the leading researchers in Inhalation and Respiratory Drug Delivery?
The most-cited researchers publishing on Inhalation and Respiratory Drug Delivery include Lídia Morawska.
- 1 Lídia Morawska Australia 6.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Inhalation and Respiratory Drug Delivery research done?
The largest centres of Inhalation and Respiratory Drug Delivery research in 2022–2025 are London (United Kingdom), Beijing (China), Shanghai (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Parma.
Largest cities, 2022–2025
Where it is the local speciality
- ParmaIT · 25.6 works18×
Location quotient: how much more of its research is in Inhalation and Respiratory Drug Delivery than the world average.
Where is the best place to study Inhalation and Respiratory Drug Delivery?
Among universities, judged by research, Shenyang Pharmaceutical University, University of Parma and University of Szeged score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Shenyang Pharmaceutical UniversityChina | 71.6 | 46.4% | 17.2× | 11 | +207.7% |
| 2 | University of ParmaItaly | 56.1 | 18.2% | 11.9× | 14 | +125.1% |
| 3 | University of SzegedHungary | 53.2 | 19.9% | 9.4× | 12 | +134.7% |
| 4 | Beni-Suef UniversityEgypt | 49.7 | 6.8% | 11.2× | 9 | +192.6% |
| 5 | Imperial College LondonUnited Kingdom | 48.5 | 19.8% | 4.9× | 22 | +58.9% |
| 6 | Soochow UniversityChina | 46.5 | 46.0% | 2.3× | 9 | +166.2% |
| 7 | University of GroningenNetherlands | 46.1 | 30.4% | 5.4× | 13 | +13.3% |
| 8 | University of Technology SydneyAustralia | 45.4 | 26.8% | 3.8× | 9 | +188.7% |
| 9 | Sichuan UniversityChina | 43.1 | 51.7% | 1.4× | 12 | +29.7% |
| 10 | University of North Carolina at Chapel HillUnited States | 41.0 | 8.2% | 4.3× | 36 | +60.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Inhalation and Respiratory Drug Delivery research growing?
Output in 2018–2022 was 28% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Inhalation and Respiratory Drug Delivery.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.